InsidersTradesSigma
Follow the INNO GENE S.A. stock price and the full insider trade history of the company, a listed issuer based in Poland. Shares are quoted on PL PL, under the authority of KNF. Operating in the Health Care sector, INNO GENE S.A. has recorded 1 reports. Market capitalisation: €29m. The latest transaction was reported on 18 May 2026 (Notification PDMR). Among the most active insiders: Anonymous (PDMR). All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.